P-225 XPD and RRM1 gene polymorphisms predict gemcitabine (gem)/cisplatin (cis)/docetaxel (doc) outcome in stage III non-small-cell lung cancer (NSCLC): a genetic analysis of the Spanish Lung Cancer Group phase II trial 9901

Author(s):

Carme Sarries ◽

Pilar Garrido ◽

Laura Nun˜ez ◽

Barbara Roig ◽

Jose Luis Ramirez ◽

...

Keyword(s):

Lung Cancer ◽

Genetic Analysis ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Gene Polymorphisms ◽

Phase Ii Trial ◽

Small Cell ◽

Small Cell Lung ◽

A phase II trial of erlotinib as maintenance treatment after concurrent chemoradiotherapy in stage III non-small-cell lung cancer (NSCLC): a Galician Lung Cancer Group (GGCP) study

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-013-2370-z ◽

2013 ◽

Vol 73 (3) ◽

pp. 451-457 ◽

Cited By ~ 5

Author(s):

J. Casal Rubio ◽

J. L. Fírvida-Pérez ◽

M. Lázaro-Quintela ◽

F. J. Barón-Duarte ◽

G. Alonso-Jáudenes ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Maintenance Treatment ◽

Concurrent Chemoradiotherapy ◽

Phase Ii Trial ◽

Small Cell ◽

Small Cell Lung ◽

P-224 XPD polymorphisms in cisplatin (cis)/vinorelbine (vrb)-treated stage IV non-small-cell lung cancer (NSCLC) patients (p): genetic analysis of a Spanish Lung Cancer Group phase II trial

Lung Cancer ◽

10.1016/s0169-5002(03)92193-3 ◽

2003 ◽

Vol 41 ◽

pp. S148 ◽

Author(s):

Nuria Vin˜olas ◽

Barbara Roig ◽

Noemi Reguart ◽

Mariano Provencio ◽

Felipe Cardenal ◽

...

Keyword(s):

Lung Cancer ◽

Genetic Analysis ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Stage Iv ◽

Small Cell ◽

Small Cell Lung ◽

Cancer Group ◽

Nsclc Patients

P-533 Single agent weekly paclitaxel chemotherapy in elderly or frailnon-small cell lung cancer (NSCLC) patients: Final results of a phase II trial Spanish Lung Cancer Group (GECP 00/02)

Lung Cancer ◽

10.1016/s0169-5002(05)81026-8 ◽

2005 ◽

Vol 49 ◽

pp. S257-S258

Author(s):

B. Massuti ◽

C. Camps ◽

P. Garrido ◽

N. Viñolas ◽

J. Barcelo ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Single Agent ◽

Small Cell ◽

Small Cell Lung ◽

Cancer Group ◽

Nsclc Patients

Topotecan and cisplatin in combination with concurrent twice-daily chemoradiation in limited disease small cell lung cancer—a Danish Oncological Lung Cancer Group (DOLG) phase II trial

Lung Cancer ◽

10.1016/j.lungcan.2007.09.022 ◽

2008 ◽

Vol 60 (2) ◽

pp. 252-258 ◽

Cited By ~ 5

Author(s):

Morten Sorensen ◽

Ulrik Lassen ◽

Torben Palshof ◽

Britta Bjerregaard Jensen ◽

Jørgen Johansen ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell ◽

Small Cell Lung ◽

Limited Disease ◽

P-21 A phase II trial of weekly paclitaxel in advanced non-small cell lung cancer non-suitable for platinum-based chemotherapy. Spanish lung cancer group/GECP 00-02

Lung Cancer ◽

10.1016/s0169-5002(03)91990-8 ◽

2003 ◽

Vol 41 ◽

pp. S96

Author(s):

Bartomeu Massutí ◽

Carlos Camps ◽

Pilar Garrido ◽

JoséRamón Barceló ◽

Núria Vin˜olas ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell ◽

Weekly Paclitaxel ◽

Small Cell Lung ◽

Cancer Group ◽

Platinum Based Chemotherapy

3067 Randomized phase II trial of standard daily administration versus alternate-day administration of S-1 in patients with advanced non-small cell lung cancer: North Japan Lung Cancer Group Trial NJLCG1102

European Journal of Cancer ◽

10.1016/s0959-8049(16)31709-9 ◽

2015 ◽

Vol 51 ◽

pp. S619

Author(s):

R. Saito ◽

A. Suzuki ◽

M. Maemondo ◽

S. Sugawara ◽

T. Nakagawa ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell ◽

Small Cell Lung ◽

Cancer Group ◽

Randomized Phase Ii ◽

Group Trial

NORA trial (GECP 15/02): Updated results of the Spanish Lung Cancer Group (SLCG) phase II trial of concurrent chemo-radiotherapy (CT-RT) with cisplatin (P) plus metronomic oral vinorelbine (mOV) for unresectable locally advanced non-small cell lung cancer (LA-NSCLC)

Annals of Oncology ◽

10.1093/annonc/mdz259.004 ◽

2019 ◽

Vol 30 ◽

pp. v594

Author(s):

M. Guirado ◽

M. Majem ◽

B. Massuti Sureda ◽

R. de las Penas Bataller ◽

A.L. Ortega Granados ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Locally Advanced ◽

Small Cell ◽

Small Cell Lung ◽

Oral Vinorelbine ◽

Preliminar analysis of the Spanish Lung Cancer Group (SLCG) phase II trial of concurrent chemo-radiotherapy (CT-RT) with cisplatin (P) plus metronomic oral vinorelbine (mOV) for unresectable locally advanced non-small cell lung cancer (LA-NSCLC): NORA trial (GECP 15/02)

Annals of Oncology ◽

10.1093/annonc/mdx379.007 ◽

2017 ◽

Vol 28 ◽

pp. v459

Author(s):

M. Majem Tarruella ◽

L. Isla Casado ◽

M. Guirado ◽

B. Massuti Sureda ◽

A.L. Ortega Granados ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Locally Advanced ◽

Small Cell ◽

Small Cell Lung ◽

Oral Vinorelbine ◽

Phase II trial of carboplatin and pemetrexed combination in elderly patients with advanced non-squamous non small cell lung cáncer (NS-NSCLC). A Galician Lung Cancer Group Study.

Journal of Clinical Oncology ◽

10.1200/jco.2015.33.15_suppl.e19017 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. e19017-e19017 ◽

Author(s):

Mª Carmen Areses Manrique ◽

Natalia Fernández Núñez ◽

Marta Covela Rúa ◽

Ana Alonso Herrero ◽

Maria Jose Villanueva Silva ◽

...

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell ◽

Small Cell Lung ◽

NORA trial (GECP 15/02): First efficacy results of the Spanish Lung Cancer Group (SLCG) phase II trial of concurrent chemo-radiotherapy (CT-RT) with cisplatin (P) plus metronomic oral vinorelbine (mOV) for unresectable locally advanced non-small cell lung cancer (LA-NSCLC).

Journal of Clinical Oncology ◽

10.1200/jco.2018.36.15_suppl.8537 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. 8537-8537 ◽

Author(s):

Dolores Isla ◽

Margarita Majem ◽

Maria Guirado ◽

Bartomeu Massuti ◽

Ramon De Las Penas ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Locally Advanced ◽

Small Cell ◽

Small Cell Lung ◽

Oral Vinorelbine ◽